Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree

Journal of Investigative Dermatology

Volumn 128, Issue 8, 2008, Pages 2122-2125

  Florell, Scott R ^a,b   Meyer, Laurence J ^a,b,c   Boucher, Kenneth M ^b   Grossman, Douglas ^a,b   Cannon Albright, Lisa A ^b   Harris, Ronald M ^a,b   Samlowski, Wolfram E ^a,b,d   Zone, John J ^a,b   Leachman, Sancy A ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEVADA CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16;

5' UNTRANSLATED REGION; CELL DENSITY; DISEASE PREDISPOSITION; FAMILY; FOLLOW UP; HUMAN; LETTER; LONGITUDINAL STUDY; MELANOCYTIC NEVUS; MELANOMA; MULTIPLE LINEAR REGRESSION ANALYSIS; MUTATION; PEDIGREE; PRIORITY JOURNAL; PROMOTER REGION; RANK SUM TEST; SKIN EXAMINATION; STATISTICAL SIGNIFICANCE; TEMPERATURE SENSITIVITY; UNITED STATES;

EID: 47349091169     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.51     Document Type: Letter

References (17)

1. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K et al. (1996) Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 73:1605-11
2. Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, McCarthy W et al. (1998) The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 77:505-10
3. Bishop JA, Wachsmuth RC, Harland M, Bataille V, Pinney E, Mac KP et al. (2000) Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 114:28-33
4. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148-52
5. Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE et al. (2006) Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol 126:660-6
6. Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM et al. (2005) Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. J Invest Dermatol 125:1310-2
7. Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J et al. (2004) Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol 123:576-82
8. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991) Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 83:1726-33
9. Goldstein AM, Tucker MA (1995) Genetic epidemiology of familial melanoma. Dermatol Clin 13:605-12
10. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA et al. (2006) Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 95:496-505
11. Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarra G, Goldstein AM et al. (2000) Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer 28:45-57
12. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W et al. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:23-6
13. Kefford RF, Mann GJ (2003) Is there a role for genetic testing in patients with melanoma? Curr Opin Oncol 15:157-61
14. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA (1999) Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 17:3245-51
15. Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N et al. (1999) Mutation of the CDKN2A 50 UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 21:128-32
16. Meyer LJ, Goldgar DE, Cannon-Albright LA, Piepkorn MW, Zone JJ, Risman MB et al. (1992) Number, size, and histopathology of nevi in Utah kindreds. Cytogenet Cell Genet 59:167-9
17. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J et al. (1986) Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 292:1555-9